GlassScriptPhysician profile
Brian J Goentzel
NPI 1194959692
$98,514.35
in general payments reported to CMS, 2019-2025
10 companies · $6,656 in 2025
The $6,656 reported for 2025 was more than what 94% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,291 · 2020: $346 · 2021: $18K · 2022: $29K · 2023: $19K · 2024: $23K · 2025: $6,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $40K · Travel and Lodging: $4,152 · Consulting Fee: $2,788 · Food and Beverage: $2,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,500.00 |
| Travel and Lodging | $4,152.14 |
| Consulting Fee | $2,787.50 |
| Food and Beverage | $2,655.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $59,746.27 | 2019-2023 | Intracept |
| Boston Scientific Corporation | $28,235.68 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $7,426.07 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $2,378.38 | 2019-2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $390.13 | 2022-2023 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $113.63 | 2022-2025 | Sprint Pns System |
| Vertiflex, INC. | $86.74 | 2019 | |
| Stryker Corporation | $82.00 | 2021 | |
| Pfizer INC. | $40.95 | 2019 | |
| Nevro Corp. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Goentzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.